Skip to main content

letter

. 1965 Jun 12;1(5449):1550. doi: 10.1136/bmj.1.5449.1550

Chemotherapy of Tuberculosis

F J C Roe, E Boyland, A Haddow

PMCID: PMC2166708 PMID: 14288112

1550

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

HEIN J., STEFANI H. Die gewebliche Reaktion der Lungentuberkulose bei Isonikotinsäurehydrazid-Behandlung. Z Tuberk. 1952;101(3-4):180–187. [PubMed] [Google Scholar]
KELLY M. G., O'GARA R. W., GADEKAR K., YANCEY S. T., OLIVERIO V. T. CARCINOGENIC ACTIVITY OF A NEW ANTITUMOR AGENT, N-ISOPROPYL-ALPHA-(2-METHYLHYDRAZINO)-P-TOLUAMIDE, HYDROCHLORIDE (NSC-77213). Cancer Chemother Rep. 1964 Jul;39:77–80. [PubMed] [Google Scholar]
POMPE K. Einfluss von Isonicotinhydrazid auf die Lupuskarzinomentstehung. Dermatol Wochenschr. 1956;133(5):105–108. [PubMed] [Google Scholar]
ROE F. J., LANCASTER M. C. NATURAL, METALLIC AND OTHER SUBSTANCES, AS CARCINOGENS. Br Med Bull. 1964 May;20:127–133. doi: 10.1093/oxfordjournals.bmb.a070305. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES